Hilary Coon, Andrey Shabalin, Amanda V. Bakian, Emily DiBlasi, Eric T. Monson, Anne Kirby, Danli Chen, Alison Fraser, Zhe Yu, Michael Staley, William Brandon Callor, Erik D. Christensen, Sheila E. Crowell, Douglas Gray, David K. Crockett, Qingqin S. Li, Brooks Keeshin, Anna R. Docherty
{"title":"Extended familial risk of suicide death is associated with younger age at death and elevated polygenic risk of suicide","authors":"Hilary Coon, Andrey Shabalin, Amanda V. Bakian, Emily DiBlasi, Eric T. Monson, Anne Kirby, Danli Chen, Alison Fraser, Zhe Yu, Michael Staley, William Brandon Callor, Erik D. Christensen, Sheila E. Crowell, Douglas Gray, David K. Crockett, Qingqin S. Li, Brooks Keeshin, Anna R. Docherty","doi":"10.1002/ajmg.b.32890","DOIUrl":null,"url":null,"abstract":"<p>Suicide accounts for >800,000 deaths annually worldwide; prevention is an urgent public health issue. Identification of risk factors remains challenging due to complexity and heterogeneity. The study of suicide deaths with increased extended familial risk provides an avenue to reduce etiological heterogeneity and explore traits associated with increased genetic liability. Using extensive genealogical records, we identified high-risk families where distant relatedness of suicides implicates genetic risk. We compared phenotypic and polygenic risk score (PRS) data between suicides in high-risk extended families (high familial risk (HFR), <i>n</i> = 1,634), suicides linked to genealogical data not in any high-risk families (low familial risk (LFR), <i>n</i> = 147), and suicides not linked to genealogical data with unknown familial risk (UFR, <i>n</i> = 1,865). HFR suicides were associated with lower age at death (mean = 39.34 years), more suicide attempts, and more PTSD and trauma diagnoses. For PRS tests, we included only suicides with >90% European ancestry and adjusted for residual ancestry effects. HFR suicides showed markedly higher PRS of suicide death (calculated using cross-validation), supporting specific elevation of genetic risk of suicide in this subgroup, and also showed increased PRS of PTSD, suicide attempt, and risk taking. LFR suicides were substantially older at death (mean = 49.10 years), had fewer psychiatric diagnoses of depression and pain, and significantly lower PRS of depression. Results suggest extended familiality and trauma/PTSD may provide specificity in identifying individuals at genetic risk for suicide death, especially among younger ages, and that LFR of suicide warrants further study regarding the contribution of demographic and medical risks.</p>","PeriodicalId":7673,"journal":{"name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","volume":"189 3-4","pages":"60-73"},"PeriodicalIF":1.6000,"publicationDate":"2022-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/08/AJMG-189-60.PMC9149029.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ajmg.b.32890","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 4
Abstract
Suicide accounts for >800,000 deaths annually worldwide; prevention is an urgent public health issue. Identification of risk factors remains challenging due to complexity and heterogeneity. The study of suicide deaths with increased extended familial risk provides an avenue to reduce etiological heterogeneity and explore traits associated with increased genetic liability. Using extensive genealogical records, we identified high-risk families where distant relatedness of suicides implicates genetic risk. We compared phenotypic and polygenic risk score (PRS) data between suicides in high-risk extended families (high familial risk (HFR), n = 1,634), suicides linked to genealogical data not in any high-risk families (low familial risk (LFR), n = 147), and suicides not linked to genealogical data with unknown familial risk (UFR, n = 1,865). HFR suicides were associated with lower age at death (mean = 39.34 years), more suicide attempts, and more PTSD and trauma diagnoses. For PRS tests, we included only suicides with >90% European ancestry and adjusted for residual ancestry effects. HFR suicides showed markedly higher PRS of suicide death (calculated using cross-validation), supporting specific elevation of genetic risk of suicide in this subgroup, and also showed increased PRS of PTSD, suicide attempt, and risk taking. LFR suicides were substantially older at death (mean = 49.10 years), had fewer psychiatric diagnoses of depression and pain, and significantly lower PRS of depression. Results suggest extended familiality and trauma/PTSD may provide specificity in identifying individuals at genetic risk for suicide death, especially among younger ages, and that LFR of suicide warrants further study regarding the contribution of demographic and medical risks.
全世界每年有80万人死于自杀;预防是一个紧迫的公共卫生问题。由于复杂性和异质性,风险因素的识别仍然具有挑战性。对家族风险增加的自杀死亡的研究为减少病因异质性和探索与遗传风险增加相关的特征提供了一条途径。利用广泛的家谱记录,我们确定了自杀的远亲关系涉及遗传风险的高危家庭。我们比较了高风险大家庭自杀(高家族风险(HFR), n = 1634)、与任何高风险家庭的家谱数据相关的自杀(低家族风险(LFR), n = 147)和与未知家族风险的家谱数据无关的自杀(UFR, n = 1865)的表型和多基因风险评分(PRS)数据。HFR自杀与较低的死亡年龄(平均39.34岁)、更多的自杀企图以及更多的PTSD和创伤诊断相关。对于PRS测试,我们只纳入了90%欧洲血统的自杀者,并调整了剩余祖先效应。HFR自杀显示出明显更高的自杀死亡PRS(使用交叉验证计算),支持该亚组中自杀遗传风险的特定升高,同时也显示出PTSD、自杀企图和冒险行为的PRS增加。LFR自杀者在死亡时的年龄大得多(平均49.10岁),有较少的精神病学诊断为抑郁和疼痛,并且抑郁的PRS显著降低。结果表明,延长的熟悉度和创伤/创伤后应激障碍可能为识别具有自杀死亡遗传风险的个体提供特异性,特别是在年轻人中,自杀的LFR值得进一步研究人口和医疗风险的贡献。
期刊介绍:
Neuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG) , provides a forum for experimental and clinical investigations of the genetic mechanisms underlying neurologic and psychiatric disorders. It is a resource for novel genetics studies of the heritable nature of psychiatric and other nervous system disorders, characterized at the molecular, cellular or behavior levels. Neuropsychiatric Genetics publishes eight times per year.